Company Profile

Abterra Biosciences Inc (AKA: Digital Proteomics LLC~Abterra Biosciences Inc)
Profile last edited on: 6/18/2021      CAGE: 6G3U6      UEI: TYHDLNB65NJ1

Business Identifier: Computational solutions for proteomics
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3030 Bunker Hill Street Suite 218
San Diego, CA 92109
   (888) 416-9305
Location: Single
Congr. District: 50
County: San Diego

Public Profile

Abterra Biosciences began life as Digital Proteomics LLC, a spin-out of the University of California – San Diego - currently resident in JLabs San Diego - delivers cutting-edge computational solutions to the proteomics community. Utilizing algorithmic and machine learning approaches, the firm's personnel are enabling effective and efficient drug discovery / development of efficient, effective tools to address core bioinformatics problems. Digital Proteomics creates high performance analytic and software tools designed to advance discovery and development in therapeutics and health and - be extnsion - removing bottlenecks in drug discovery. Antibodies, for example, are a rapidly growing class of therapeutics across a range of indications, including oncology, immunology, and infectious diseases. Antibody therapeutics were previously developed primarily in rodents and then humanized. The shift has been to have antibody therapeutics becomed more human™. The premise is tht. despite the success of human antibodies as therapeutics, the natural human immune system has been underutilized as a source of therapeutic candidates. Humans survive a wide range of immunological challenges and produce antibodies that were crucial in overcoming the illness. Digital Proteomics personnel have developed Alicanto® to discover antibodies from survivors to develop into therapeutics

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Natalie Castellana -- CEO

  Vineet Bafna -- Co-Founder

  Stefano Bonissone -- CSO

  Thiago Lima -- Senior Scientist

  Anand Patel -- CTO

  Anand Patel

  Pavel Pevzner -- Co-Founder

Company News

There are no news available.